|
1
|
Final version of 2009 AJCC melanoma staging and classification.
|
J Clin Oncol
|
2009
|
23.08
|
|
2
|
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.
|
J Clin Oncol
|
2010
|
2.30
|
|
3
|
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline--Update 2012.
|
Eur J Cancer
|
2012
|
2.05
|
|
4
|
Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.
|
J Clin Oncol
|
2011
|
1.78
|
|
5
|
Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1.
|
Clin Cancer Res
|
2011
|
1.52
|
|
6
|
Randomized dose-escalation study evaluating peginterferon alfa-2a in patients with metastatic malignant melanoma.
|
J Clin Oncol
|
2006
|
0.95
|
|
7
|
Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012".
|
J Transl Med
|
2013
|
0.95
|
|
8
|
Hyperthermic pelvic perfusion with tumor necrosis factor-α for locally advanced cancers: encouraging results of a phase II study.
|
Ann Surg
|
2012
|
0.86
|
|
9
|
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.
|
J Transl Med
|
2014
|
0.80
|
|
10
|
Gene expression profiling of human angiotropic primary melanoma: selection of 15 differentially expressed genes potentially involved in extravascular migratory metastasis.
|
Eur J Cancer
|
2011
|
0.77
|
|
11
|
Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008.
|
Pigment Cell Melanoma Res
|
2009
|
0.76
|